Transforming Leukemia & Thalassemia Care
Tracks
Plenary Hall
| Sunday, September 6, 2026 |
| 10:15 AM - 12:45 PM |
Speaker
Dr. Mark Litzow
Professor of Medicine
Mayo Clinic College of Medicine and Science
ALL Diagnosis & Management in 2026: Incorporating New Therapies
10:15 AM - 10:35 AM
Prof. Ali Taher
Professor of Medicine in Hematology & Oncology at the American University of Beirut Medical Center
Director of Naef K. Basile Cancer Institute, and Associate VP for Academic Centers
Fixing the Factory, Not Just the Product: Targeting Ineffective Erythropoiesis in Thalassemia
10:35 AM - 10:55 AM
Dr. Mark J. Levis
Director, Adult Leukemia Service
Professor of Oncology and Patholog, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AML Management in 2026
10:55 AM - 11:15 AM
Dr. Mark Litzow
Professor of Medicine
Mayo Clinic College of Medicine and Science
Management of PH Positive ALL in 2026
11:15 AM - 11:35 AM
Dr. Mark J. Levis
Director, Adult Leukemia Service
Professor of Oncology and Patholog, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Management of AML Relapse After Allogeneic HCT
11:35 AM - 11:55 AM
TBC
Updates in CML Management
11:55 AM - 12:15 PMSession Chair
Somaya Alnuaimi
Pediatric Hematologist
Fujairah Hospital
Ahmad Tarawah
President, Madinah Hereditary Blood Disorders Society
President, Middle East and North Africa Hematology League
